BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 7814872)

  • 1. Characterization of donor chimerism, alloreactive host T cells and memory cell development in thymi from mice resistant to neonatal transplantation tolerance.
    Ruiz P; Nassiri M; Viciana AL; Padmanabhan J; Streilein JW
    J Immunol; 1995 Jan; 154(2):633-43. PubMed ID: 7814872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid organ production of immunomodulatory eicosanoids in mice resistant to neonatal tolerance induction.
    Nassiri M; Viciana A; Padmanabhan J; Streilein JW; Ruiz P
    Transplantation; 1994 Jun; 57(11):1643-52. PubMed ID: 8009599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
    Tomita Y; Khan A; Sykes M
    J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
    J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal transplantation tolerance is associated with a systemic reduction in memory cells, altered chimeric cell phenotype, and modified eicosanoid and cytokine production.
    Ruiz P; Nassiri M; Gregorian S; Viciana AL; Streilein JW
    Transplantation; 1996 Apr; 61(8):1198-205. PubMed ID: 8610418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice.
    Rodríguez-Barbosa JI; Haller GW; Zhao G; Sachs DH; Sykes M
    Transpl Immunol; 2005 Oct; 15(1):25-33. PubMed ID: 16223670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific skin transplants activate allodestructive T cells in mice resistant to neonatal H-2 tolerance induction.
    Nassiri M; Viciana A; Streilein JW; Ruiz P
    Transplantation; 1993 Dec; 56(6):1460-7. PubMed ID: 8279020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatally tolerant rats actively eliminate donor-specific lymphocytes despite persistent chimerism.
    Cutler AJ; Bell EB
    Eur J Immunol; 1996 Feb; 26(2):320-8. PubMed ID: 8617298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in mice.
    Jánossy T; Baranyi L; Knulst AC; Vizler C; Benner R; Kelényi G; Végh P
    Eur J Immunol; 1993 Nov; 23(11):3011-20. PubMed ID: 8223878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that I-E-negative mice resistant to neonatal H-2 tolerance induction display ubiquitous thymic clonal deletion of donor-reactive T cells.
    Ruiz P; Streilein JW
    Transplantation; 1993 Feb; 55(2):321-8. PubMed ID: 8434383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of I-E expression on induction of neonatal transplantation tolerance.
    Streilein JW; Socarras S; Powell TJ
    Eur J Immunol; 1991 Feb; 21(2):261-6. PubMed ID: 1999218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cytotoxic cells in mice rendered neonatally tolerant of MHC alloantigens: evidence for repertoire modification.
    Wood PJ; Strome PG; Streilein JW
    J Immunol; 1987 Jun; 138(11):3661-8. PubMed ID: 2884256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.